Reuters: Moderna Snaps Up Japan's OriCiro Genomics In MRNA Manufacturing Push Moderna Inc (MRNA.O) on Wednesday agreed to buy Japan-based OriCiro Genomics for $85 million to boost the U.S. drugmaker's messenger RNA (mRNA) manufacturing capabilities. (1/4)